1. Home
  2. IPW vs PFSA Comparison

IPW vs PFSA Comparison

Compare IPW & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iPower Inc.

IPW

iPower Inc.

BUY

Current Price

$0.40

Market Cap

1.1M

ML Signal

BUY

Logo Profusa Inc.

PFSA

Profusa Inc.

BUY

Current Price

$0.94

Market Cap

902.5K

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
IPW
PFSA
Founded
2018
2009
Country
United States
United States
Employees
4
N/A
Industry
Catalog/Specialty Distribution
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1M
902.5K
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
IPW
PFSA
Price
$0.40
$0.94
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.8M
★ 2.6M
Earning Date
10-02-2026
11-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $19,956,938.00
$100,000.00
Revenue This Year
$596.00
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.34
$0.89
52 Week High
$4,092,187,400.00
$90,000.00

Technical Indicators

Market Signals
Indicator
IPW
PFSA
Relative Strength Index (RSI) 24.74 36.32
Support Level N/A $0.89
Resistance Level $1.57 $24.50
Average True Range (ATR) 0.16 0.21
MACD 34.28 0.30
Stochastic Oscillator 4.85 3.52

Price Performance

Historical Comparison
IPW
PFSA

About IPW iPower Inc.

iPower Inc is a technology-enabled commerce infrastructure company providing supply chain, logistics, fulfillment, warehousing and procurement solutions for e-commerce and distribution channels. Its product portfolio includes hydroponic products, gardening supplies, home goods and related accessories, with gardening and home products. Geographically, the company generates majority of its revenue from the United States, followed by Canada and other international markets.

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term. The Lumee Oxygen Platform has been designed for use in applications where monitoring of compromised tissue is beneficial, such as peripheral artery disease that results in narrowing of blood vessels and reduced blood flow to the lower limbs; chronic wounds that do not heal properly; and reconstructive surgery.

Share on Social Networks: